Sivik Global Healthcare LLC Sells 30,000 Shares of Surgery Partners, Inc. (NASDAQ:SGRY)

Sivik Global Healthcare LLC trimmed its holdings in shares of Surgery Partners, Inc. (NASDAQ:SGRY) by 13.0% during the fourth quarter, Holdings Channel.com reports. The fund owned 200,000 shares of the company’s stock after selling 30,000 shares during the quarter. Surgery Partners accounts for about 2.2% of Sivik Global Healthcare LLC’s holdings, making the stock its 20th biggest position. Sivik Global Healthcare LLC’s holdings in Surgery Partners were worth $4,234,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Quarry LP grew its position in shares of Surgery Partners by 133.1% during the 2nd quarter. Quarry LP now owns 3,082 shares of the company’s stock worth $73,000 after purchasing an additional 1,760 shares in the last quarter. KBC Group NV raised its position in shares of Surgery Partners by 31.8% in the third quarter. KBC Group NV now owns 2,385 shares of the company’s stock valued at $77,000 after buying an additional 576 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. boosted its stake in shares of Surgery Partners by 747.6% in the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company’s stock valued at $124,000 after buying an additional 3,379 shares during the period. Creative Planning acquired a new stake in Surgery Partners during the third quarter worth approximately $258,000. Finally, Versor Investments LP bought a new position in Surgery Partners during the 3rd quarter worth $271,000.

Wall Street Analyst Weigh In

SGRY has been the subject of a number of recent analyst reports. Bank of America began coverage on Surgery Partners in a research report on Monday, December 16th. They set a “buy” rating and a $30.00 target price for the company. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $43.00 price objective on shares of Surgery Partners in a research report on Friday, October 4th. KeyCorp started coverage on shares of Surgery Partners in a report on Friday, October 11th. They issued a “sector weight” rating on the stock. Macquarie reaffirmed an “outperform” rating and set a $34.00 price target on shares of Surgery Partners in a report on Tuesday, November 19th. Finally, JPMorgan Chase & Co. reduced their price target on shares of Surgery Partners from $38.00 to $28.00 and set a “neutral” rating on the stock in a research report on Tuesday, December 3rd. One research analyst has rated the stock with a sell rating, three have issued a hold rating and seven have issued a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $36.56.

Surgery Partners Stock Down 0.1 %

SGRY stock opened at $25.72 on Thursday. The stock has a market capitalization of $3.27 billion, a P/E ratio of -53.78, a price-to-earnings-growth ratio of 14.10 and a beta of 2.58. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99. The firm has a 50-day moving average price of $21.52 and a 200-day moving average price of $27.08. Surgery Partners, Inc. has a 12 month low of $19.50 and a 12 month high of $35.29.

Surgery Partners (NASDAQ:SGRY) last issued its quarterly earnings data on Tuesday, November 12th. The company reported $0.19 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.06). The company had revenue of $770.40 million during the quarter, compared to the consensus estimate of $768.99 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. Surgery Partners’s revenue for the quarter was up 14.3% on a year-over-year basis. During the same period in the previous year, the company earned $0.15 EPS. As a group, equities research analysts anticipate that Surgery Partners, Inc. will post 0.71 EPS for the current fiscal year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.